Mason Street Advisors LLC Acquires New Stake in ICU Medical Inc. (ICUI)
Mason Street Advisors LLC acquired a new stake in shares of ICU Medical Inc. (NASDAQ:ICUI) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,829 shares of the company’s stock, valued at approximately $319,000.
A number of other institutional investors also recently bought and sold shares of the stock. Virginia Retirement System bought a new position in ICU Medical during the first quarter valued at about $333,000. Teachers Advisors Inc. increased its position in ICU Medical by 13.3% in the first quarter. Teachers Advisors Inc. now owns 202,753 shares of the company’s stock valued at $21,107,000 after buying an additional 23,812 shares during the last quarter. JPMorgan Chase & Co. increased its position in ICU Medical by 63.5% in the first quarter. JPMorgan Chase & Co. now owns 185,078 shares of the company’s stock valued at $19,267,000 after buying an additional 71,891 shares during the last quarter. Menta Capital LLC increased its position in ICU Medical by 157.1% in the first quarter. Menta Capital LLC now owns 5,400 shares of the company’s stock valued at $562,000 after buying an additional 3,300 shares during the last quarter. Finally, M&T Bank Corp increased its position in ICU Medical by 3.3% in the first quarter. M&T Bank Corp now owns 2,117 shares of the company’s stock valued at $220,000 after buying an additional 67 shares during the last quarter. 89.50% of the stock is currently owned by institutional investors and hedge funds.
Shares of ICU Medical Inc. (NASDAQ:ICUI) opened at 149.65 on Friday. The firm has a market capitalization of $2.41 billion, a PE ratio of 44.57 and a beta of 0.37. The stock has a 50 day moving average of $126.14 and a 200-day moving average of $112.44. ICU Medical Inc. has a 12 month low of $85.56 and a 12 month high of $150.37.
ICU Medical (NASDAQ:ICUI) last announced its earnings results on Monday, August 8th. The company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.10. The business had revenue of $96.70 million for the quarter, compared to analysts’ expectations of $89.66 million. ICU Medical had a net margin of 14.94% and a return on equity of 10.33%. The company’s quarterly revenue was up 15.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.97 EPS. On average, equities research analysts anticipate that ICU Medical Inc. will post $4.54 EPS for the current fiscal year.
ICUI has been the topic of several recent analyst reports. Zacks Investment Research downgraded shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Tuesday, July 12th. Piper Jaffray Cos. reiterated a “neutral” rating and issued a $119.00 target price (up from $115.00) on shares of ICU Medical in a research report on Thursday, August 11th.
In other ICU Medical news, CFO Scott E. Lamb sold 1,474 shares of the business’s stock in a transaction on Tuesday, September 13th. The shares were sold at an average price of $121.61, for a total value of $179,253.14. Following the transaction, the chief financial officer now directly owns 4,705 shares of the company’s stock, valued at approximately $572,175.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Joseph R. Saucedo sold 2,000 shares of the business’s stock in a transaction on Friday, July 29th. The shares were sold at an average price of $115.47, for a total transaction of $230,940.00. Following the completion of the transaction, the director now directly owns 4,348 shares in the company, valued at $502,063.56. The disclosure for this sale can be found here. 15.90% of the stock is currently owned by company insiders.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical Inc. (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.